Prof. Kezhen Li 李科珍
Chief Physician, Professor
Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of cervical precancerous lesions, cervical cancer, ovarian cancer, endometrial cancer, and trophoblastic diseases.
Dr. Li is a Chief Physician and Professor with nearly ten years of clinical experience in obstetrics and gynecology. Dr. Li focuses on benign and malignant gynecological tumors, with in-depth research into uterine and ovarian tumors.
Name order: in Chinese the family name comes first (Li Kezhen). Papers usually list the name as Kezhen Li or Li K.
Selected publications
93 papers on PubMed matched by name and affiliation; 32 as first or senior author since 2016. Most recent first- or senior-author papers:
- Mater Horiz, 2026 (senior author): Bioinspired plant-derived extracellular vesicles enabling dual-targeting therapy for primary ovarian insufficiency. PubMed 42710041
- J Gynecol Oncol, 2026 (senior author): Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trial. PubMed 42172490
- Int J Gynecol Cancer, 2026 (senior author): Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial. PubMed 41582028
- Biomedicines, 2026 (senior author): From Maternal Exposure to F1 Development: Unveiling Cyclophosphamide-Induced Reproductive Toxicity. PubMed 42351781
- J Extracell Vesicles, 2026 (senior author): Nanomotor-Driven Extracellular Vesicles With Effective Tissue Penetration for Targeted Therapy of Primary Ovarian Insufficiency. PubMed 41764599
- Biomark Res, 2026 (senior author): Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors. PubMed 41535994
- Reprod Biomed Online, 2025 (senior author): Maternal exposure to paclitaxel had a temporary adverse impact on oocyte quality but did not affect developmental competence in offspring. PubMed 40839900
- Stem Cell Res Ther, 2025 (senior author): Precision medicine in premature ovarian insufficiency: a focus on the precision therapeutic strategies for mesenchymal stem cells. PubMed 40671085
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion